In our analysis of HER2, IL-6, and pSTAT3 levels in a panel of primary IBCs, we found substantial co-localization of HER2 and pSTAT3, consistent with pSTAT3 as a known key regulator of growth in HER2pos breast cancer cells [53,54]. Here, ERBB2 is linked to breast carcinoma.